Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies

Get started →

Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

9851

1

Nuwellis, Inc. Nuwellis Reports Improved Financials, Net Income Turnaround in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9852

1

Rhinebeck Bancorp, Inc. Rhinebeck Bancorp Reports Net Loss of $8.1M in Q3 2024, Net Loss of $6.0M for Nine Months

Via official filing (AI summary) | 6 months ago | 0 comments

9853

1

Ares Acquisition Corp II Ares Acquisition Corporation II Reports Net Income Growth, Doubts on Going Concern

Via official filing (AI summary) | 6 months ago | 0 comments

9854

1

NORTHWEST BIOTHERAPEUTICS INC Northwest Biotherapeutics Reports Significant Revenue Growth, But Continues to Face Financial Challenges

Via official filing (AI summary) | 6 months ago | 0 comments

9855

1

iANTHUS CAPITAL HOLDINGS, INC. iAnthus Capital Holdings Reports Mixed Financial Results for Q3 and Nine Months Ended September 30, 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9856

1

Electromed, Inc. Electromed, Inc. Reports 19% Revenue Growth and Improved Profitability in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9857

1

PSYCHEMEDICS CORP Psychemedics Reports 9% Revenue Decline, Reduces Operating Expenses, and Plans Reverse/Forward Stock Split

Via official filing (AI summary) | 6 months ago | 0 comments

9858

1

TERAWULF INC. TeraWulf Reports Revenue Growth, Net Loss in Latest Quarter

Via official filing (AI summary) | 6 months ago | 0 comments

9859

1

Pioneer Bancorp, Inc./MD Pioneer Bancorp Reports Strong Financial Growth and Strategic Progress in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9860

1

PowerFleet, Inc. PowerFleet Reports 124.9% Revenue Growth in Q3 2024, Net Loss Despite MiX Telematics Acquisition

Via official filing (AI summary) | 6 months ago | 0 comments

9861

1

LISATA THERAPEUTICS, INC. Lisata Therapeutics Reports Third Quarter and Nine Months Financial Results, Focuses on Clinical Development Efforts

Via official filing (AI summary) | 6 months ago | 0 comments

9862

1

Rumble Inc. Rumble Inc. Reports Revenue Growth, Narrowing Losses in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9863

1

FIBROGEN INC FibroGen Reports 15% Revenue Growth, Improved Net Loss in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9864

1

CXApp Inc. CXApp Inc. Reports Mixed Financial Results, Widening Net Loss Despite Revenue Growth

Via official filing (AI summary) | 6 months ago | 0 comments

9865

1

MARINUS PHARMACEUTICALS, INC. Marinus Pharmaceuticals Reports Revenue Growth, Net Loss, and Significant Financial Changes in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9866

1

DYADIC INTERNATIONAL INC Dyadic International Reports Significant Revenue Growth, Improved Profitability in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9867

1

Atara Biotherapeutics, Inc. Atara Biotherapeutics Reports Significant Revenue Growth, Net Loss Reduction in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

9868

1

Lionsgate Studios Corp. Lionsgate Studios Reports Mixed Financial Results, Net Loss Amid Revenue Growth

Via official filing (AI summary) | 6 months ago | 0 comments

9869

1

MARIN SOFTWARE INC Marin Software Reports Mixed Q3 Results, Declining Revenues but Improved Gross Profit Margins

Via official filing (AI summary) | 6 months ago | 0 comments

9870

1

Artiva Biotherapeutics, Inc. Artiva Biotherapeutics Reports Significant Financial Developments, Including Increased Assets and Net Loss

Via official filing (AI summary) | 6 months ago | 0 comments

9871

1

COLOMBIER ACQUISITION CORP. II Colombier Acquisition Corp. II Reports Financial Performance Following IPO, Net Income Turnaround

Via official filing (AI summary) | 6 months ago | 0 comments

9872

1

Prime Medicine, Inc. Prime Medicine Reports Strong Financials, Collaboration Revenue Growth, and Strategic Partnerships in Latest 10-Q Filing

Via official filing (AI summary) | 6 months ago | 0 comments

9873

1

CARGO Therapeutics, Inc. Cargo Therapeutics Reports Significant Financial Developments, Including Decrease in Cash Reserves and Increased Losses

Via official filing (AI summary) | 6 months ago | 0 comments

9874

1

Oncocyte Corp Oncocyte Corporation Reports Significant Financial Challenges in Latest 10-Q Filing

Via official filing (AI summary) | 6 months ago | 0 comments

9875

1

Korro Bio, Inc. Korro Bio Reports Significant Changes in Financial Position and Performance, Anticipates Continued Operating Losses

Via official filing (AI summary) | 6 months ago | 0 comments